Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Invivyd (IVVD) granted stock options as inducement awards to six newly hired non-executive employees on September 1, 2026.

Rhea-AI Summary

Invivyd (IVVD) granted stock options as inducement awards to six newly hired non-executive employees on September 1, 2026.

The employees received options to purchase an aggregate of 255,000 shares of Invivyd common stock under the 2026 Inducement Plan, in accordance with Nasdaq Listing Rule 5635(c)(4). The options have a per share exercise price of $0.8799, equal to the closing price on the grant date, and a 10-year term. Each option vests over four years, with 25% vesting on the first anniversary of the employee’s start date and the remainder vesting in equal monthly installments thereafter, subject to continuous service.

News Explained

Invivyd has granted options covering 255,000 shares to six new employees; if the options are exercised, they could increase shares outstanding and dilute existing holders, subject to four-year vesting.

Argus Sep 3 session 1 alert

+3.86% close to close 3.3x rel. volume Open Argus

Details

Market move: IVVD +3.86% in the Sep 3 session. inducement grant announcement

$253.37M Mkt Cap at Peak Alert

On Sep 3, the day this news came out, IVVD closed 3.86% above the previous close. Relative volume reached 3.3x the daily average during tracking.

Data tracked by StockTitan Argus for the Sep 3 session.

Key Figures

Employees Granted Options: 6 employees Aggregate Shares: 255,000 shares Exercise Price: $0.8799 per share +3 more

Employees Granted Options

6 employees

September 1, 2026 grant

Aggregate Shares

255,000 shares

Employee stock options

Exercise Price

$0.8799 per share

Closing price on grant date

Vesting Period

4 years

Subject to continuous employee service

Initial Vesting

25%

Vests on the first anniversary of the employee's start date

Option Term

10 years

Under the 2026 Inducement Plan

Historical Context

5 past events · Latest: Sep 01

5 events

1. Sep 01

   Leadership change

   24h Move

   -7.8%

   Chairman became CEO as VYD2311 results approached

2. Aug 13

   Q2 earnings report

   24h Move

   +5.1%

   Revenue growth coincided with higher expenses and increased net loss

3. Aug 04

   Inducement grants

   24h Move

   +3.9%

   Ten employees received options for 277,500 shares

4. Jul 06

   EUA update

   24h Move

   -6.7%

   PEMGARDA EUA termination notice was received from FDA

5. Jul 02

   Inducement grants

   24h Move

   +4.6%

   Fourteen employees received options for 493,000 shares

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

Nasdaq Listing Rule 5635(c)(4)

1 terms

Nasdaq Listing Rule 5635(c)(4) regulatory

"The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on September 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of 255,000 shares of its common stock, each as a material inducement for each employee’s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan. 

The options have a per share exercise price of $0.8799, representing the closing price of Invivyd’s common stock on the grant date. Each option vests over four years, with 25% of the shares subject to such option vesting on the first anniversary of the employee’s start date and the remaining shares vesting in equal monthly installments thereafter, in each case, subject to the employee’s continuous service with Invivyd. The options have a 10-year term and are subject to the terms of the Invivyd, Inc. 2026 Inducement Plan. 

About Invivyd   

Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.  

This press release contains hyperlinks to information that is not deemed to be incorporated by reference in this press release. 

Contacts: 

Media Relations 
(781) 208-0160 
media@invivyd.com 

Investor Relations 
(781) 208-1747 
investors@invivyd.com 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What inducement grants did Invivyd (IVVD) announce on September 3, 2026?

Invivyd announced stock option grants to six newly hired non-executive employees, covering an aggregate of 255,000 shares of common stock as material inducement awards tied to their employment.

What are the key terms of the Invivyd (IVVD) inducement stock options?

The options have a per share exercise price of $0.8799, a 10-year term, and vest over four years: 25% on the first anniversary of each employee’s start date and the remainder in equal monthly installments, subject to continuous service.

Under what plan and Nasdaq rule were the Invivyd (IVVD) inducement options granted?

The inducement options were granted under the Invivyd 2026 Inducement Plan and structured in accordance with Nasdaq Listing Rule 5635(c)(4), which governs equity awards granted as a material inducement to employment.